CS2164 combined with radiation suppressed tumor growth via γ-H2AX persistence and ROS accumulation
Abstract Background CS2164 is an oral multi-target inhibitor that targets angiogenesis-related kinases, mitosis-related kinases, and chronic inflammation-related kinases. However, the added clinical benefit of CS2164 combined with radiation remains unknown. Methods The anti-tumor effect of CS2164 co...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2026-03-01
|
| Seri Bilgileri: | BMC Cancer |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12885-026-15865-y |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|